Drug-induced hypersensitivity syndrome with superficial granulomatous dermatitis-A novel finding

American Journal of Dermatopathology

Volumn 31, Issue 6, 2009, Pages 611-613

  Fernando, Suran L ^a,b   Henderson, Christopher J ^c   O'Connor, Kate S ^d  

^a ROYAL NORTH SHORE HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c LIVERPOOL HOSPITAL   (Australia)

^d WESTMEAD HOSPITAL   (Australia)

Author keywords

Anticonvulsant hypersensitivity syndrome; Drug induced granulomatous reaction; Drug induced hypersensitivity syndrome; Granulomatous dermatitis

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CARBAMAZEPINE; DIPEPTIDYL CARBOXYPEPTIDASE; GAMMA GLUTAMYLTRANSFERASE; IMMUNOGLOBULIN G; PREDNISONE;

ACANTHOSIS; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CASE REPORT; CERVICAL LYMPHADENOPATHY; COMPUTER ASSISTED TOMOGRAPHY; DERMOEPIDERMAL JUNCTION; DRESS SYNDROME; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ENZYME BLOOD LEVEL; EOSINOPHIL; EOSINOPHIL COUNT; ERYTHRODERMA; EXOCYTOSIS; EXTRAVASATION; EYE JAUNDICE; FACE EDEMA; FEMALE; FEVER; FOLLOW UP; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GRANULOMA; HEPATITIS; HEPATOSPLENOMEGALY; HISTOPATHOLOGY; HUMAN; HUMAN HERPESVIRUS 6; HYPERKERATOSIS; LEUKOCYTOSIS; LIVER FUNCTION TEST; LOW BACK PAIN; LYMPHOCYTE; LYMPHOCYTOSIS; MACULOPAPULAR RASH; PRIORITY JOURNAL; RASH; SKIN BIOPSY; SKIN INFLAMMATION; SKIN PRURITUS; VIRUS REACTIVATION; VIRUS TITRATION;

ADULT; ANALGESICS; ANTI-INFLAMMATORY AGENTS; CARBAMAZEPINE; DERMATITIS; DRUG HYPERSENSITIVITY; FEMALE; GRANULOMA; HEPATITIS; HUMANS; LOW BACK PAIN; PEPTIDYL-DIPEPTIDASE A; PREDNISONE;

EID: 68949163529     PISSN: 01931091     EISSN: None     Source Type: Journal    
DOI: 10.1097/DAD.0b013e3181a18d64     Document Type: Article

References (21)

1. Solensky R. Drug hypersensitivity. Med Clin North Am. 2006;90:233-260.
2. Shiohara T, Kano Y. A complex interaction between drug allergy and viral infection. Clin Rev Allergy Immunol. 2007;33:124-133.
3. Bohan KH, Mansuri TF,Wilson NM. Anticonvulsant hypersensitivity syndrome: implications for pharmaceutical care. Pharmacotherapy. 2007;27:1425.
4. Gogtay NJ, Bavdekar SB, Kshirsagar NA. Anticonvulsant hypersensitivity syndrome: a review. Expert Opin Drug Saf. 2005;4:571.
5. Hashimoto K, Yasukawa M, Tohyama M. Human herpes virus 6 and drug allergy. Curr Opin Allergy Clin Immunol. 2003;3:255-260.
6. Siohara T, Inaoka M, Kano Y. Drug induced hypersensitivity syndrome (DIHS): a reaction induced by a complex interplay among herpes viruses and antiviral and antidrug immune responses. Allergol Int. 2006;55:1-8
7. Kano Y, Hirahara K, Sakuma K, et al. Several herpesviruses can reactivate in a severe drug-induced multiorgan reaction in the same sequential order as graft-versus-host disease. Br J Dermatol. 2006;155:301-306.
8. Hegarty J, Picton M, Agarwal G, et al. Carbamazepine-induced acute granulomatous interstitial nephritis. Clin Nephrol. 2002;57:310-313.
9. Imai H, Nakamoto Y, Hirokawa M, et al. Carbamazepine-induced granulomatous necrotizing angiitiswith acute renal failure. Nephron. 1989;51:405-408.
10. Swinburn BA, Croxson MS, Miller MV, et al. Carbamazepine induced granulomatous hepatitis. N Z Med J. 1986;99:167.
11. Mitchell MC, Boitnott JK, Arregui A, et al. Granulomatous hepatitis associated with carbamazepine therapy. Am J Med. 1981;71:733-735.
12. Levy M, Goodman MW, Van Dyne BJ, et al. Granulomatous hepatitis secondary to carbamazepine. Ann Intern Med. 1981;95:64-65.
13. Perrin C, Lacour JP, Castanet J, et al. Interstitial granulomatous drug reaction with a histological pattern of interstitial granulomatous dermatitis. Am J Dermatopathol. 2001;23:295-298.
14. Magro CM, Crowson AN, Schaprio BL. The interstitial granulomatous drug reaction: a distinctive clinical and pathological entity. J Cutan Pathol. 1998;25:72-78.
15. Baughman RP, Teirstein AS, Judson MA, et al. Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med. 2001;164:1885.
16. Baughman RP. Pulmonary sarcoidosis. Clin Chest Med. 2004;25:521.
17. Roberts SD, Mirowski GW, Wilkes D, et al. Sarcoidosis. Part II: extrapulmonary and systemic manifestations. J Am Acad Dermatol. 2004; 51:628.
18. English III JC, Patel PJ, Greer KE. Sarcoidosis. J Am Acad Dermatol. 2001;44:725.
19. Mana J, Marcoval J, Graells J, et al. Cutaneous involvement in sarcoidosis. Relationship to systemic disease. Arch Dermatol. 1997;133:882.
20. Beneteau-Burnat B, Baudin B. Angiotensin-converting enzyme: clinical applications and laboratory investigations on serum and other biological fluids. Crit Rev Clin Lab Sci. 1991;28:337-356.
21. Britton WJ. Hypersensitivity (Type IV). In: Male D, Brostoff J, Roth DB, et al, eds. Immunology.Vol 7. Philadelphia, PA: Mosby Elsevier; 2006:477-491.